Adam's Blogroll: click through to the author's blog
A California court has dismissed virologist Judy Mikovits’s lawsuit against fourteen people and two Nevada corporations, in part because she failed to submit necessary documents on time. Mikovits is the author on a now-retracted Science paper suggesting a link between a virus known as XMRV and chronic fatigue syndrome, which has no known cause. She alleged that she was fired […]
The post Court dismisses lawsuit by XMRV-chronic fatigue syndrome researcher appeared first on Retraction Watch.
Posted by in dismissed, for legal reasons, infectious disease, judy mikovits, Legal Threats, pathology
Following questions from outside experts, a retraction of a related paper, a university investigation and a court case, The Lancet has decided to retract a 1992 paper by Ranjit Kumar Chandra, the self-proclaimed “father of nutritional immunology.” In a lengthy retraction note included in the January 30 issue, the journal explains that: the balance of probabilities […]
The post Lancet retracts 24-year-old paper by “father of nutritional immunology” after reopening inquiry appeared first on Retraction Watch.
The authors of a paper on a mechanism for potential cancer therapies are retracting it after realizing they published some proprietary findings “without permission and agreement from St. Jude Children’s Research Hospital.” According to the retraction note in Journal of the American Chemical Society, the authors included an X-ray crystal structure and data that were […]
The post Intellectual property issues sink cancer paper in JACS appeared first on Retraction Watch.
A 2014 article in Occupational Medicine has been pulled with no retraction notice. Instead, the text was replaced with eight ominous words: This article has been removed for legal reasons The title of the paper appears to have been scrubbed from the journal’s table of contents, but in PubMed it is indexed with the title […]
The post Lead poisoning article disappears for “legal” — but mysterious — reasons appeared first on Retraction Watch.
What’s in a name? Well, if it’s the same name as a treatment with nearly $1 billion in sales per year in the U.S., a retraction. A “mind numbingly boring one,” that is. Here’s the Twin Research and Human Genetics notice for “EpiPen: An R Package to Investigate Two-Locus Epistatic Models”: The paper ‘EpiPen: An R […]
The post Drug company lawyer letter results in “utterly tedious” retraction appeared first on Retraction Watch.
A group of researchers at Bristol-Myers Squibb has had a paper retracted for reasons we can’t quite figure out.
All the notice for “Simultaneous expression of antibody light and heavy chains in Pichia pastoris: improving retransformation outcome by linearizing vector at a different site,” published in Applied Microbiology and Biotechnology, says is:
This article has been retracted due to unsolved legal reasons.
It’s unclear what this means. The ten authors of the paper are at Bristol-Myers Squibb’s Biologics Process Sciences division of its Global Manufacturing and Supply operation in East Syracuse, New York. Neither the corresponding author, the editor of the journal, nor Bristol-Myers Squibb has responded to our requests for comment.
Pichia pastoris is a yeast that, according to Wikipedia, is
widely used for protein expression using recombinant DNA techniques. Hence it is used in biochemical and genetic research in academia and the biotechnical industry.
“Unsolved legal reasons” seems to be a favorite at Springer, which publishes the journal. We reported on two other retractions for the same “reason” last month.
